周美玲，博士，教授，硕士研究生导师，四川省“卫生健康英才计划”中青年骨干人才。主持国家自然科学基金、四川省科技厅项目和泸州市科技厅项目等各级课题10余项。以第一或通讯作者在Journal of Controlled Release、Journal of Nanobiotechnology、Acta Biomaterialia等国际期刊发表SCI论文30余篇，IF>10分4篇，中国科学院1区9篇，入选ESI高被引论文2篇（全球Top 1%）。获国家发明专利授权2项。获四川省医学会青年优秀论文，西南医科大学优秀兼职班主任，西南医科大学附属医院十佳青年科技工作者、科研业绩优秀个人、发表高质量论文通讯作者奖等荣誉。指导学生连续两年获得全国大学生基础医学创新研究暨实验设计论坛国家级银奖。
研究方向：新型药物递送系统研究；临床药物治疗研究
单位：西南医科大学附属医院药学部/西南医科大学药学院临床药学教研室
E-mail: meilzhou@163.com
学习及工作经历：
2025.12-至今：西南医科大学附属医院，教授
2020.12-2025.11：西南医科大学附属医院，副教授
2017.07-2020.11：西南医科大学附属医院，讲师
2012.09-2017.06：四川大学华西药学院，博士
2008.09-2012.06：四川大学华西药学院，学士
代表性科研项目：
1. 国家自然科学基金青年基金，82104083，2022.01.01-2024.12.31，主持；
2. 四川省科技厅自然科学基金，2025ZNSFSC1732，2025.01.01-2026.12.31，主持；
3. 四川省科技厅苗子工程项目，2018RZ0120，2018.07.01-2021.06.30，主持；
4. 泸州市人民政府-西南医科大学科技战略合作项目，2023LZXNYDJ004，2023.10.01-2026.09.30，主持；
5. 泸州市科技厅项目，2018-JYJ-40，2018.06-2020.05，主持；
6. 西南医科大学临床医学专项青年人才培育项目，2025LCYXZX13，2025.11-2028.10，主持。
代表性论文：
(1) Zhang Z, Wang G, Zhang Z, Liang X, Wang G, Xu M, Yang X, Zhong X, Li C*, Zhou M*. Locally administered liposomal drug depot enhances rheumatoid arthritis treatment by inhibiting inflammation and promoting cartilage repair. Journal of Nanobiotechnology, 2025, 23(1):69. (IF = 10.6, 中国科学院1区)
(2) Liang X, Yu X, Liu Y, He X, Ding K, Tan X, Li Q, Zhao T, Lan Y, Zhou M*, Li C*. NIR-controlled photothermal intelligent nanozyme synergizes catalysis and gas therapy for multidimensional treatment of inflammatory bowel disease. Journal of Nanobiotechnology, 2025, 23(1):800. (IF = 12.6, 中国科学院1区)
(3) Zheng X, Zhang Z, Zheng Y, Liu Y, Wu C, Liang X, Yang X, Tang J, He X, Li C*, Wang G*, Zhou M*. Thermosensitive light-driven smart platform induces apoptosis of fibroblast-like synovial cells and macrophages for enhanced rheumatoid arthritis therapy. ACS Applied Materials & Interfaces, 2025, 17:25035-25047. (IF = 8.5, 中国科学院2区)
(4) Wu S, Chen Y, Wang K, Huang M, Yang L, Yang J, Wei Q, Tao C, Li C*, Zhou M*. Multifunctional mesoporous polydopamine nanoplatforms for synergistic photothermal-chemotherapy and enhanced immunotherapy in breast cancer treatment. Colloids and Surfaces B: Biointerfaces, 2025, 248:114483. (IF = 5.4, 中国科学院2区)
(5) Ding Q, Shang J, Yang L, Deng L, Wu S, Chen J, Yang J, Wang K, Li C, Chen J*, Zhou M*. Enhanced anti-tumor efficacy of berberine-loaded mesoporous polydopamine nanoparticles for synergistic chemotherapy and photothermal therapy. International Journal of Pharmaceutics, 2025, 670:125151. (IF = 5.3, 中国科学院2区)
(6) Shang J, Chen Y, Wang F, Yang J, Li Y, Yang L, Liu X, Zhong Z, Yue C*, Zhou M*. A multifunctional MIL-101-NH2(Fe) nanoplatform for synergistic melanoma therapy. International Journal of Nanomedicine, 2025, 20:969-988. (IF = 6.7, 中国科学院2区)
(7) Ai Z, Liu B, Chen J, Zeng X, Wang K, Tao C, Chen J, Yang L, Ding Q*, Zhou M*. Advances in nano drug delivery systems for enhanced efficacy of emodin in cancer therapy. International Journal of Pharmaceutics: X, 2025, 9:100314. (IF = 5.2, 中国科学院2区, ESI高被引论文)
(8) Yang L, Shang J, Fan Q, Deng L, Yang J, Wang K, Tao C, Jing P, Dai Y, Ding Q*, Zhou M*. Honokiol-loaded ZIF-90 nanoparticles modified with polydopamine for antitumor therapy. ACS Applied Nano Materials, 2024, 7(22):25823-25834. (IF = 5.3, 中国科学院2区)
(9) Long J, Liang X, Ao Z, Tang X, Li C, Yan K, Yu X, Wan Y, Li Y*, Li C*, Zhou M*. Stimulus-responsive drug delivery nanoplatforms for inflammatory bowel disease therapy. Acta Biomaterialia, 2024, 188:27-47. (IF = 9.4, 中国科学院1区)
(10) Liu Y#, Zhou M#, Xu M#, Wang X, Zhang Y, Deng Y, Zhang Z, Jiang J, Zhou X*, Li C*. Reprogramming monocytes into M2 macrophages as living drug depots to enhance treatment of myocardial ischemia-reperfusion injury. Journal of Controlled Release, 2024, 374:639-652. (IF = 10.5, 中国科学院1区)
(11) Yang J, Shang J, Yang L, Wei D, Wang X, Deng Q, Zhong Z, Ye Y, Zhou M*. Nanotechnology-based drug delivery systems for honokiol: enhancing therapeutic potential and overcoming limitations. International Journal of Nanomedicine, 2023, 18:6639-6665. (IF = 8, 中国科学院2区)
(12) Li H, Feng Y, Zheng X, Jia M, Mei Z, Wang Y, Zhang Z*, Zhou M*, Li C*. M2-type exosomes nanoparticles for rheumatoid arthritis therapy via macrophage re-polarization. Journal of Controlled Release, 2022, 341: 16-30. (IF = 9.776, 中国科学院1区, ESI高被引论文)
(13) Chen L, Lin Y, Zhang Z, Yang R, Bai X, Liu Z, Luo Z, Zhou M*, Zhong Z*. A novel dual-prodrug carried by cyclodextrin inclusion complex for the targeting treatment of colon cancer. Journal of Nanobiotechnology, 2021, 19:329. (IF = 10.435, 中国科学院2区)
(14) Zhang R, Wu S, Ding Q, Fan Q, Dai Y, Guo S, Ye Y, Li C*, Zhou M*. Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy. Drug Delivery, 2021, 28(1):1109-1119. (IF = 6.419, 中国科学院2区)
(15) Li J, Wei J, Wan Y, Du X, Bai X, Li C, Lin Y, Liu Z, Zhou M*, Zhong Z*. TAT-modified tetramethylpyrazine-loaded nanoparticles for targeted treatment of spinal cord injury. Journal of Controlled Release, 2021, 335:103-116. (IF = 9.776, 中国科学院1区)
(16) Liang T, Zhang R, Liu X, Ding Q, Wu S, Li C, Lin Y, Ye Y, Zhong Z*, Zhou M*. Recent advances in macrophage-mediated drug delivery systems. International Journal of Nanomedicine, 2021, 16:2703-2714. (IF = 5.115, 中国科学院2区)
(17) Liu X, Liang T, Zhang R, Ding Q, Wu S, Li C, Lin Y, Ye Y*, Zhong Z*, Zhou M*. Iron-based metal-organic frameworks in drug delivery and biomedicine. ACS Applied Materials & Interfaces, 2021, 13(8):9643-9655. (IF = 8.758, 中国科学院1区)
(18) Wang Y, Liu Z, Li T, Chen L, Lyu J, Li C, Lin Y, Hao N, Zhou M*, Zhong Z*, Enhanced therapeutic effect of RGD-modified polymeric micelles loaded with low-dose methotrexate and nimesulide on rheumatoid arthritis. Theranostics, 2019, 9(3):708-720. (IF = 8.537, 中国科学院1区)
(19) Zhou M, Li J, Li C, Guo L, Wang X, He Q, Fu Y*, Zhang Z*, Tertiary amine mediated targeted therapy against metastatic lung cancer, Journal of Controlled Release, 2016, 241: 81-93. (IF = 7.786, 中国科学院1区)
